Dr. Raymond Goodrich is widely recognized as a leading expert in transfusion and transplantation medicine and pathogen reduction technologies. Further, he is the expert on the application of the protective dye riboflavin (Vitamin B2) as a safe, effective means of inactivating pathogens.
Having spent over three decades in infectious disease medical research, Ray has honed the unique ability to conduct and oversee translational research that leads to the commercialization of products, services, and methods. He has over 50 medical technology patents and has co-authored over 200 peer-reviewed articles and abstracts.
As a Singletto Strategic Advisor and leader of Singletto-sponsored research, Ray applies his institutional knowledge in infectious disease and pathogen reduction to the ongoing efforts of Singletto to bring pathogen-destroying singlet oxygen solutions to the marketplace.
Ray is currently serving as the Executive Director of the Infectious Disease Research Center (IDRC) at Colorado State University, where his research focuses on transfusion-transmitted infections and the development of methods to produce vaccine candidates for infectious diseases and cancer immunotherapy applications. He received his Ph.D. in biophysical chemistry from the California Institute of Technology.